EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragon, Miguel Servet University Hospital, Zaragoza, Spain.
San Pablo Primary Care Health Centre, Aragon Health Service (SALUD), Zaragoza, Spain.
PLoS One. 2024 Feb 12;19(2):e0298195. doi: 10.1371/journal.pone.0298195. eCollection 2024.
The COVID-19 pandemic has created unprecedented challenges for health care systems globally. This study aimed to explore the presence of mental illness in a Spanish cohort of COVID-19-infected population and to evaluate the association between the presence of specific mental health conditions and the risk of death and hospitalization. This is a retrospective cohort study including all individuals with confirmed infection by SARS-CoV-2 from the PRECOVID (Prediction in COVID-19) Study (Aragon, Spain). Mental health illness was defined as the presence of schizophrenia and other psychotic disorders, anxiety, cognitive disorders, depression and mood disorders, substance abuse, and personality and eating disorders. Multivariable logistic regression models were used to examine the likelihood of 30-day all-cause mortality and COVID-19 related hospitalization based on baseline demographic and clinical variables, including the presence of specific mental conditions, by gender. We included 144,957 individuals with confirmed COVID-19 from the PRECOVID Study (Aragon, Spain). The most frequent diagnosis in this cohort was anxiety. However, some differences were observed by sex: substance abuse, personality disorders and schizophrenia were more frequently diagnosed in men, while eating disorders, depression and mood, anxiety and cognitive disorders were more common among women. The presence of mental illness, specifically schizophrenia spectrum and cognitive disorders in men, and depression and mood disorders, substance abuse, anxiety and cognitive and personality disorders in women, increased the risk of mortality or hospitalization after COVID-19, in addition to other well-known risk factors such as age, morbidity and treatment burden. Identifying vulnerable patient profiles at risk of serious outcomes after COVID-19 based on their mental health status will be crucial to improve their access to the healthcare system and the establishment of public health prevention measures for future outbreaks.
新型冠状病毒肺炎大流行给全球卫生保健系统带来了前所未有的挑战。本研究旨在探讨西班牙新型冠状病毒肺炎感染人群中精神疾病的发生情况,并评估特定心理健康状况与死亡和住院风险之间的关系。这是一项回顾性队列研究,纳入了来自西班牙阿拉贡 PRECOVID(新型冠状病毒肺炎预测)研究的所有经 SARS-CoV-2 确诊感染的个体。精神疾病定义为精神分裂症和其他精神病性障碍、焦虑症、认知障碍、抑郁症和心境障碍、物质使用障碍以及人格和饮食障碍的存在。多变量逻辑回归模型用于根据基线人口统计学和临床变量(包括特定精神状况的存在),按性别检查 30 天全因死亡率和新型冠状病毒肺炎相关住院的可能性。我们纳入了来自西班牙阿拉贡 PRECOVID 研究的 144957 例经新型冠状病毒肺炎确诊的个体。该队列中最常见的诊断是焦虑症。然而,性别之间存在一些差异:男性中更常诊断出物质使用障碍、人格障碍和精神分裂症,而女性中更常见的是饮食障碍、抑郁症和心境障碍、焦虑症和认知障碍。精神疾病的存在,特别是男性中的精神分裂症谱系和认知障碍,以及女性中的抑郁症和心境障碍、物质使用障碍、焦虑症和认知及人格障碍,除了年龄、发病率和治疗负担等其他已知风险因素外,还增加了新型冠状病毒肺炎后的死亡或住院风险。根据精神健康状况确定有发生严重结局风险的脆弱患者特征,对于改善他们获得卫生保健系统的机会和为未来疫情制定公共卫生预防措施至关重要。